(DKNG) DraftKings - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US26142V1052
Sports Betting, Fantasy Sports, Online Casino, Digital Collectibles, Retail Sportsbooks
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 47.5% |
| Value at Risk 5%th | 77.3% |
| Relative Tail Risk | -1.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.38 |
| Alpha | -38.73 |
| CAGR/Max DD | 0.70 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.461 |
| Beta | 1.150 |
| Beta Downside | 1.445 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.80% |
| Mean DD | 15.99% |
| Median DD | 14.31% |
Description: DKNG DraftKings October 16, 2025
DraftKings Inc. (NASDAQ:DKNG) is a Boston-based digital sports entertainment firm that operates both online and retail sportsbooks, daily fantasy sports platforms, and iGaming casino games such as blackjack, roulette, baccarat, and slots. The company also licenses its betting-software to third-party operators and runs a digital collectibles marketplace that sells curated NFTs.
Key recent metrics (Q2 2024): revenue grew 23 % YoY to $1.12 bn, driven primarily by a 31 % increase in sportsbook volume; adjusted EBITDA margin expanded to 12 % from 9 % a year earlier, reflecting higher gross margins on iGaming and software licensing. The sector’s growth is closely tied to the U.S. regulatory environment-more than 30 states now allow online sports betting, and further liberalization is expected to lift total addressable market (TAM) by an estimated $30 bn over the next five years.
For a deeper dive into DraftKings’ valuation assumptions and scenario analysis, you may find ValueRay’s analytical tools useful.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (-267.6m TTM) > 0 and > 6% of Revenue (6% = 327.5m TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA 11.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 3.09% (prev -0.06%; Δ 3.15pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 667.6m > Net Income -267.6m (YES >=105%, WARN >=100%) |
| Net Debt (100.8m) to EBITDA (44.9m) ratio: 2.25 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.09 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (529.5m) change vs 12m ago 8.91% (target <= -2.0% for YES) |
| Gross Margin 47.57% (prev 38.50%; Δ 9.07pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 122.7% (prev 107.8%; Δ 14.90pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -6.01 (EBITDA TTM 44.9m / Interest Expense TTM 37.1m) >= 6 (WARN >= 3) |
Altman Z'' -6.50
| (A) 0.04 = (Total Current Assets 1.95b - Total Current Liabilities 1.78b) / Total Assets 4.62b |
| (B) -1.42 = Retained Earnings (Balance) -6.57b / Total Assets 4.62b |
| warn (B) unusual magnitude: -1.42 — check mapping/units |
| (C) -0.05 = EBIT TTM -222.7m / Avg Total Assets 4.45b |
| (D) -1.68 = Book Value of Equity -6.54b / Total Liabilities 3.89b |
| Total Rating: -6.50 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 51.34
| 1. Piotroski 5.0pt |
| 2. FCF Yield 4.12% |
| 3. FCF Margin 11.34% |
| 4. Debt/Equity 1.81 |
| 5. Debt/Ebitda 2.25 |
| 6. ROIC - WACC (= -18.53)% |
| 7. RoE -29.52% |
| 8. Rev. Trend 91.38% |
| 9. EPS Trend 80.52% |
What is the price of DKNG shares?
As of December 03, 2025, the stock is trading at USD 33.61 with a total of 10,641,534 shares traded.
Over the past week, the price has changed by +6.13%, over one month by +9.94%, over three months by -29.85% and over the past year by -23.49%.
Over the past week, the price has changed by +6.13%, over one month by +9.94%, over three months by -29.85% and over the past year by -23.49%.
Is DKNG a buy, sell or hold?
DraftKings has received a consensus analysts rating of 4.47.
Therefore, it is recommended to buy DKNG.
- Strong Buy: 20
- Buy: 7
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the DKNG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.8 | 33.3% |
| Analysts Target Price | 44.8 | 33.3% |
| ValueRay Target Price | 32.8 | -2.4% |
DKNG Fundamental Data Overview November 25, 2025
Market Cap USD = 14.93b (14.93b USD * 1.0 USD.USD)
P/E Forward = 17.4825
P/S = 2.7351
P/B = 20.3857
Beta = 1.609
Revenue TTM = 5.46b USD
EBIT TTM = -222.7m USD
EBITDA TTM = 44.9m USD
Long Term Debt = 1.84b USD (from longTermDebt, last quarter)
Short Term Debt = 11.5m USD (from shortTermDebt, last quarter)
Debt = 1.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 100.8m USD (from netDebt column, last quarter)
Enterprise Value = 15.03b USD (14.93b + Debt 1.33b - CCE 1.23b)
Interest Coverage Ratio = -6.01 (Ebit TTM -222.7m / Interest Expense TTM 37.1m)
FCF Yield = 4.12% (FCF TTM 619.0m / Enterprise Value 15.03b)
FCF Margin = 11.34% (FCF TTM 619.0m / Revenue TTM 5.46b)
Net Margin = -4.90% (Net Income TTM -267.6m / Revenue TTM 5.46b)
Gross Margin = 47.57% ((Revenue TTM 5.46b - Cost of Revenue TTM 2.86b) / Revenue TTM)
Gross Margin QoQ = 71.27% (prev 43.50%)
Tobins Q-Ratio = 3.25 (Enterprise Value 15.03b / Total Assets 4.62b)
Interest Expense / Debt = 1.47% (Interest Expense 19.6m / Debt 1.33b)
Taxrate = -4.93% (negative due to tax credits) (12.1m / -244.7m)
NOPAT = -233.7m (EBIT -222.7m * (1 - -4.93%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 1.09 (Total Current Assets 1.95b / Total Current Liabilities 1.78b)
Debt / Equity = 1.81 (Debt 1.33b / totalStockholderEquity, last quarter 732.3m)
Debt / EBITDA = 2.25 (Net Debt 100.8m / EBITDA 44.9m)
Debt / FCF = 0.16 (Net Debt 100.8m / FCF TTM 619.0m)
Total Stockholder Equity = 906.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.79% (Net Income -267.6m / Total Assets 4.62b)
RoE = -29.52% (Net Income TTM -267.6m / Total Stockholder Equity 906.4m)
RoCE = -8.12% (EBIT -222.7m / Capital Employed (Equity 906.4m + L.T.Debt 1.84b))
RoIC = -8.99% (negative operating profit) (NOPAT -233.7m / Invested Capital 2.60b)
WACC = 9.54% (E(14.93b)/V(16.26b) * Re(10.25%) + D(1.33b)/V(16.26b) * Rd(1.47%) * (1-Tc(-0.05)))
Discount Rate = 10.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.36%
[DCF Debug] Terminal Value 61.20% ; FCFE base≈408.3m ; Y1≈268.0m ; Y5≈122.6m
Fair Price DCF = 3.51 (DCF Value 1.75b / Shares Outstanding 497.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 80.52 | EPS CAGR: 38.02% | SUE: -1.55 | # QB: 0
Revenue Correlation: 91.38 | Revenue CAGR: 26.53% | SUE: -1.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.27 | Chg30d=+0.030 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=1.72 | Chg30d=-0.256 | Revisions Net=-5 | Growth EPS=+153.3% | Growth Revenue=+22.4%
P/E Forward = 17.4825
P/S = 2.7351
P/B = 20.3857
Beta = 1.609
Revenue TTM = 5.46b USD
EBIT TTM = -222.7m USD
EBITDA TTM = 44.9m USD
Long Term Debt = 1.84b USD (from longTermDebt, last quarter)
Short Term Debt = 11.5m USD (from shortTermDebt, last quarter)
Debt = 1.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 100.8m USD (from netDebt column, last quarter)
Enterprise Value = 15.03b USD (14.93b + Debt 1.33b - CCE 1.23b)
Interest Coverage Ratio = -6.01 (Ebit TTM -222.7m / Interest Expense TTM 37.1m)
FCF Yield = 4.12% (FCF TTM 619.0m / Enterprise Value 15.03b)
FCF Margin = 11.34% (FCF TTM 619.0m / Revenue TTM 5.46b)
Net Margin = -4.90% (Net Income TTM -267.6m / Revenue TTM 5.46b)
Gross Margin = 47.57% ((Revenue TTM 5.46b - Cost of Revenue TTM 2.86b) / Revenue TTM)
Gross Margin QoQ = 71.27% (prev 43.50%)
Tobins Q-Ratio = 3.25 (Enterprise Value 15.03b / Total Assets 4.62b)
Interest Expense / Debt = 1.47% (Interest Expense 19.6m / Debt 1.33b)
Taxrate = -4.93% (negative due to tax credits) (12.1m / -244.7m)
NOPAT = -233.7m (EBIT -222.7m * (1 - -4.93%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 1.09 (Total Current Assets 1.95b / Total Current Liabilities 1.78b)
Debt / Equity = 1.81 (Debt 1.33b / totalStockholderEquity, last quarter 732.3m)
Debt / EBITDA = 2.25 (Net Debt 100.8m / EBITDA 44.9m)
Debt / FCF = 0.16 (Net Debt 100.8m / FCF TTM 619.0m)
Total Stockholder Equity = 906.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.79% (Net Income -267.6m / Total Assets 4.62b)
RoE = -29.52% (Net Income TTM -267.6m / Total Stockholder Equity 906.4m)
RoCE = -8.12% (EBIT -222.7m / Capital Employed (Equity 906.4m + L.T.Debt 1.84b))
RoIC = -8.99% (negative operating profit) (NOPAT -233.7m / Invested Capital 2.60b)
WACC = 9.54% (E(14.93b)/V(16.26b) * Re(10.25%) + D(1.33b)/V(16.26b) * Rd(1.47%) * (1-Tc(-0.05)))
Discount Rate = 10.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.36%
[DCF Debug] Terminal Value 61.20% ; FCFE base≈408.3m ; Y1≈268.0m ; Y5≈122.6m
Fair Price DCF = 3.51 (DCF Value 1.75b / Shares Outstanding 497.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 80.52 | EPS CAGR: 38.02% | SUE: -1.55 | # QB: 0
Revenue Correlation: 91.38 | Revenue CAGR: 26.53% | SUE: -1.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.27 | Chg30d=+0.030 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=1.72 | Chg30d=-0.256 | Revisions Net=-5 | Growth EPS=+153.3% | Growth Revenue=+22.4%
Additional Sources for DKNG Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle